Introduction
The use of preoperative and postoperative mammograms in cosmetic surgery has never been standardized. There appears to be some consensus that at least preoperative mammograms should be obtained according to the recommendations of the American Cancer Society for screening mammography. Women at average risk should begin monthly self-breast examination at age 20, receive a clinical breast examination every 3 years from age 20 to age 39, and receive an annual mammogram and clinical breast examination starting at age 40 [1] . There is no specific surveillance strategy for women at higher risk for breast cancer, but these patients may benefit by earlier initiation of screening, screening at shorter intervals, and screening with additional methods such as ultrasound or magnetic resonance imaging [1].
Preoperative Mammograms
The purpose of a preoperative mammogram is to detect any significant disorder of the breast(s) prior to cosmetic surgery so that the problem can be resolved before surgery or during surgery. Also, the mammogram is a baseline for detecting abnormalities after the cosmetic surgery.
The incidence of new breast cancer cases is increasing at a yearly rate and was estimated to be 203,500 in 2002 [2] and 211,300 in 2003 in the United States [3] .
It is essential to detect an early cancer so that cosmetic procedures of the breast do not cut across, distort, diminish the opportunity for cure of, or limit the usefulness of lumpectomy in the treatment of the cancer. Breast cancer is now being detected-through the use of mammograms-earlier in the development of the tumor, at a smaller size, and with a better prognosis for cure.
The detection of a fibroadenoma is significant because carcinoma may occur within the fibroadenoma [4] [5] [6] [7] [8] [9] [10] . The average age for fibroadenoma is 23, whereas the average age for carcinoma in the fibroadenoma is 43 [4] . A new tumor after age 35 should be biopsied (most commonly with stereotactic needle biopsy). Under age 35, a fibroadenoma would need to be biopsied or excised if it continues to grow.
The 18-39-year-old patient is in the age group of most common debate concerning whether to perform preoperative mammograms. This age group has not had a high incidence of breast cancer, but because of earlier diagnosis, there is presently a higher incidence than previously reported. The average breast cancer tumor size in the author's practice was 3.0 cm from 1964 through 1984, but from 1985 to 2006 it was 2.0 cm, showing that earlier diagnosis was being made through mammographic screening methods and better patient awareness of the need for regular examinations. Breast cancer has been reported in patients under the age of 30 [11] . The youngest patient with cancer seen by this author was 16 years of age. An argument by radiologists has been that youthful breasts have marked dysplasia on mammography that prevents the detection of some abnormalities. But by increasing the radiation slightly to eliminate some of the dysplastic changes, a mammogram can be performed that will then focus on architectural distortion and calcifications.
Patients with a significant family history of breast cancer should begin to have annual mammograms 10 years before the youngest age of the individual(s) in the family with the cancer. If a patient with a significant family history desires breast augmentation, then the patient must be forewarned that the implant could possibly reduce the chance of early detection of cancer, and consideration must be given to placing the implants beneath the pectoralis major muscle.
Postoperative Mammograms Following Cosmetic Breast Surgery
Following cosmetic breast surgery, routine mammograms (6-12 months postoperatively) help formulate a baseline for future detection of breast cancer. Surgery
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Cosmetic Surgeries
Breast Augmentation
The insertion of implants through the areola or periareolar incisions usually involves dissection through the breast tissues, which may result in architectural scars within the breast tissue. Axillary, inframammary, and umbilical approaches do not usually breach the breast tissue itself. Calcifications have been reported in the fibrous capsule (around the implant) but do not resemble the calcifications seen with breast cancer [12] [13] [14] [15] [16] [17] . For implants in place for more than 12 years, 52.5% of those ruptured showed calcification, but only 10.0% of intact implants showed calcification [13] .
Fat transfer into the breast parenchyma is no longer performed [18] . The fat for augmentation is now injected beneath, into, and above the pectoralis muscle, although the patient should be forewarned of the possibility of inadvertent injection into the breast itself. The calcifications around a fat cyst are easily diagnosed as benign [19] . Stippled calcifications of fat necrosis following fat injection appear circular and smooth and can usually be distinguished by an experienced mammographer from calcifications found with cancer. If there is any question, the calcified area can be sampled through stereotactic needle biopsy under local anesthesia.
Kinoshita et al. [20] stated that in some magnetic resonance (MR) findings of fat necrosis it was difficult to distinguish benign from malignant lesions. Kurtz et al. [21] studied MR findings in patients with fat necrosis and found that all of the 15 fat necroses displayed fat-isointense signal on T1-weighted and on protonweighted, fat-suppressed sequences. They were delineated by a more or less wide rim of low signal intensity with a sharp border to the center. After intravenous injection of gadopenetate dimeglumine, they showed no increase in signal intensity in the center and no increase, or a minor increase, of the rim. Ultrasound could not distinguish fat necrosis from recurrent tumor in six cases, although seven looked like atypical cysts. MR mammography was felt to be a promising method for diagnosing fat necrosis.
Bilgen et al.
[22] studied 126 fat necrosis lesions in 94 patients. On mammogram, they found radiolucent oil cysts (34 or 26.9%), round opacity (16% or 12.6%), asymmetric opacity or heretogenicity of the subcutaneous tissues (20% or 15.8%), dystrophic calcifications (5% or 3.9%), and suspicious spiculated mass (5% or 3.9%).
Follow-up mammograms showed curvilinear calcifications in five and decreased density in six rounded opacities, with another two disappearing. Eleven dystrophic calcifications became more course, six of the asymmetric opacities became vague, one developed an oil cyst and coarse calcifications, and one spiculated mass developed a small radiolucent oil cyst in the center. On sonogram, the lesions were solid in 18 (9.5%), anechoic with posterior acoustic enhancement in 21 (16.6%), anechoic with posterior acoustic shadowing in 20 (15.8%), cystic with internal echoes in 14 (11.1%), and cystic with mural nodule in five (3.9%). There was increased echogenicity of the subcutaneous tissues in 34 (26.9%), and 14 (11.1%) were normal. Follow-up ultrasound showed that 18 of the 29 that had increased subcutaneous tissue echogenicity turned back to normal, while small cysts formed in the remaining 11. In the 19 solid-appearing masses, 15 showed decreases in size, while four remained stable (biopsy disclosed fat necrosis). The four complex masses increased in size and appeared more cystic. It was concluded that knowledge of the mammographic and ultrasound appearance of fat necrosis and evolution of these patterns may enable imaging followup and reduce the number of biopsies.
Breast Reduction
Breast reduction involves cutting into and removing areas of breast tissue, which may result in significant scarring, architectural distortion, and calcifications, usually from fat necrosis [23] . Miller et al. [24] noted that after reduction mammoplasty, all patients are left with a linear scar between the nipple and inframammary fold that accounts for the frequent finding of skin thickening along the lower breast. Fat necrosis presents as an irregular calcified mass. Brown et al. [25] noted that asymmetric densities were present in approximately half of the patients. Parenchymal calcifications were apparent in 50% of patients after 2 years. Four out of 42 patients had biopsies for suspicious densities, which were benign on pathology.
Abboud et al. [26] reported that breast reduction using liposuction has been associated with calcifications from fat necrosis. Sixty patients with breast reduction-34 with and 26 without liposuction-were studied. There was a 6-30-month follow-up, and calcifications were noted in 11%. Deep intraparenchymal calcifications were more frequent after liposuction, and most (five of seven) were macrocalcifications. None could be confused with malignant calcifications because they were more scattered, more regular, and less numerous. (If there is any question as to the cause of calcifications, stereotactic needle biopsy should be per-
